About Publications

Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.

  • Released: October 22, 2007
    A recent report acknowledged the impetus provided by the creation in 2004 of the Office of the National Coordinator for Health Information Technology (ONC) within the U.S. Department of Health and Human Services, and applauded the Department’s 10-year goal for creation of the National Health Information Infrastructure and the high priority given to the creation of standards. This report responds to a request by ONC for IOM to convene a Committee of experts (the Committee) to review and comment on the pace and cohesion of the standards activities it coordinates.
  • Released: October 18, 2007
    On April 18 and 19, 2007, the Institute of Medicine’s (IOM’s) Forum on Neuroscience and Nervous System Disorders, in response to a request from the U.S. Secretary of Health and Human Services, hosted a workshop called “Autism and the Environment: Challenges and Opportunities for Research.” The goal of the workshop was to provide a venue to bring together scientists, members of the autism community, and the major sponsors of autism-related research to discuss the most promising scientific opportunities.
  • Released: October 17, 2007
    At the request of the Department of Veterans Affairs, the Institute of Medicine’s Committee on Treatment of Posttraumatic Stress Disorder (PTSD) undertook a systematic review of the PTSD literature. After nearly 2,800 abstracts were identified, the application of inclusion criteria narrowed the list down to 90 randomized clinical trials, 37 pharmacotherapy studies, and 53 psychotherapy studies. The principal finding of the committee is that the scientific evidence on treatment modalities for PTSD does not reach the level of certainty that would be desired for such a common and serious condition among veterans.
  • Released: October 15, 2007
    Cancer care today often provides state-of-the-science biomedical treatment, but fails to address the psychological and social (psychosocial) problems associated with the illness. Today, it is not possible to deliver good-quality cancer care without addressing patients’ psychosocial health needs. All patients with cancer and their families should expect and receive cancer care that ensures the provision of appropriate psychosocial health services. The National Institutes of Health (NIH) asked the Institute of Medicine (IOM) to study the delivery of psychosocial services to cancer patients and their families and identify ways to improve it.
  • Released: October 05, 2007
    What works in quality improvement? What methods are currently being used to assess and identify best practices? What programs and methods should be pursued in the future? These questions are addressed in The State of Quality Improvement and Implementation Research: Expert Views, Workshop Summary by the Institute of Medicine. The IOM Forum on the Science of Health Care Quality Improvement and Implementation invited experts both from within and outside of health care to provide a better understanding of what is known about quality improvement and implementation research.
  • Released: September 25, 2007
    In 2006, spurred in part by concerns about the H5N1 virus, Congress allocated $39 million in supplemental funding for DoD-GEIS to improve this surveillance network by upgrading the capabilities of its domestic and overseas laboratories. Afterward, DoD-GEIS management asked the Institute of Medicine to form a committee that would evaluate how well DoD-GEIS had spent the supplemental funds.
  • Released: September 18, 2007
    During an influenza pandemic, healthcare workers will be on the front lines delivering care to patients and preventing further spread of the disease. One vital aspect of pandemic influenza planning is the use of personal protective equipment (PPE) that will be used by healthcare workers and others in their day-to-day patient care responsibilities. In 2006, the National Personal Protective Technology Laboratory (NPPTL) at the National Institute for Occupational Safety and Health (NIOSH) asked the Institute of Medicine (IOM) to conduct a study on the personal protective equipment needed by healthcare workers in the event of an influenza pandemic.
  • Released: September 10, 2007
    To better understand the types and magnitude of resources required to achieve the goals of the IOM report, the IOM’s Forum on Drug Discovery, Development, and Translation convened a 1-day symposium in March 2007. The symposium addressed the financial implications of many of the IOM’s recommendations, including strengthening the scientific base of the agency, integrating pre- and postmarket review, enhancing postmarket safety monitoring, conducting confirmatory drug safety and efficacy studies, improving clinical trial registration, and bolstering FDA’s regulatory and enforcement authority. The proceedings of the symposium are summarized in Challenges for the FDA: The Future of Drug Safety, Workshop Summary.
  • Released: August 20, 2007
    The Committee on Evaluation of the Presumptive Disability Decision-Making Process for Veterans was charged with describing the current process of how presumptive disability decisions are made for veterans who have health conditions attributed to military service and with proposing a scientific framework for making such presumptive disability decisions in the future. The resulting report, Improving the Presumptive Disability Decision-Making Process for Veterans, concludes that the presumptive disability decision-making process should be based on evidence about military exposures and veterans’ health and if a specific health condition for a specified group of veterans was at least as likely as not to have been caused by their military service.
  • Released: August 20, 2007
    The Institute of Medicine’s National Cancer Policy Forum held a workshop and released the proceedings entitled Cancer-Related Genetic Testing and Counseling. The workshop focused on the fact that genetic testing and counseling are becoming more complex and important for informing patients and families of the risks and benefits of certain courses of action, but at the same time organized expert programs are in short supply. The workshop covered the scientific and clinical aspects of genetic testing and counseling as well as workforce and reimbursement issues, among others.